Ulrich von Andrian

Scientific Advisor at Cygnal Therapeutics

Dr. von Andrian is the Mallinckrodt Professor of Immunopathology at Harvard Medical School, a post he has held since 2006. He is also the program leader in basic immunology and a member of the steering committee at the Ragon Institute at MGH, MIT, and Harvard. After completing his medical degree and doctoral research in Germany at the Ludwig-Maximilians University, Dr. von Andrian completed a postdoctoral fellowship at the La Jolla Institute for Experimental Medicine in California. He also completed a second postdoctoral fellowship in pathology at Stanford University Medical Center. Dr. von Andrian joined Harvard Medical School’s faculty in 1994. Since then, he has held additional professorships, and he has served on numerous editorial boards, including the boards of Cell, Science, Journal of Experimental Medicine, and Immunity.

Dr. von Andrian’s laboratory has uncovered the interaction between the peripheral sensory neurons and organs of the immune system. The lab’s discoveries open new gateways into the search for novel therapeutics for modulation of the immune response in both cancer and inflammation.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Cygnal Therapeutics

Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology.


Industries

Employees

11-50

Links